DELOS |
ibuprofen and naproxen |
Micronization and determination of solubility |
Ibuprofen showed same solubility profile, both in CO2-expanded ethanol and CO2–expanded acetone mixtures; whereas the naproxen solubility was greatly dependent on the nature of the solvent i.e. high in CO2–expanded ethanol. |
[88] |
RESOLV |
Gambogic acid |
Nanoparticles of gambogic acid were prepared to improve solubility. |
Results outlined successfully preparation of nanosuspension of gambogic acid. Extended solubility data was correlated with density-based models that suggested enhanced bioavailability and antineoplastic efficacy of nanosized gambogic acid. |
[89] |
DELOS |
Phytosterol |
Nanonization and decrease crystallinity of phytosterol to modify solubility |
Phytosterol nanoparticles were formulated through fast cooling, The crystallinity of the impregnated phytosterols was found to decrease in comparison to the pure phytosterol that modified water solubility. |
[90] |
RESOLV |
Poly (l-lactide) (PLLA) nanoparticles loaded with retinyl palmitate |
Nanoparticles of PLLA retinyl palmitate were developed with Pluronic F127, F68 and sodium dodecyl sulfate |
Spherical PLLA- retinyl palmitate nanoparticles were prepared that possessed mean size of 40–110 nm with improved solubility and great retinyl palmitate loading. |
[91] |
RESOLV |
Fenofibrate |
Precipitation and stabilization as ultrafine particles of fenofibrate |
The mean particle size was approximately 3 μm, which suggested improved solubility. The particles were found to be stable for 24 h. |
[92] |
GAS |
Resveratrol [REMOVED HYPERLINK FIELD] and isoniazid, nicotinamide |
Co-crystals of resveratrol were prepared with isoniazid and nicotinamide using CO2 antisolvent |
The developed co-crystals exhibited enhanced bioavailability when compared to original resveratrol. |
[93] |
GAS |
5-fluorouracil |
Halloysite clay nanocarrier was developed to obtain high drug loading of 5-fluorouracil |
Prepared nanocarrier loaded with 5-fluorouracil released significantly high drug release at pH 7.4 owing to improve solubility. |
[94] |
SSI |
Quercetin |
Quercetin was impregnated on Silica to enhance solubility |
Several parameters i.e. temperature, time, pressure, and different cosolvents in the supercritical impregnation process were reported influential for quercetin solubility. |
[95] |
SSI |
Promogran |
Promogran was embedded on a spilanthol-enriched extract to modify solubility |
Jambu extract that is completely soluble in fluid phase, was used to demonstrate enhanced solubility of promogran. A 4 h processing period was used for complete dissolution of the extract in SCF. |
[96] |
ASES |
Irbesartan |
Development of Irbesartan micro-particles and its composite micro-particles |
Results highlighted modified solubility (7.5 times) and dissolution rate of Irbesatan microparticles compared to pure drug. |
[97] |
ASES |
β-sitosterol |
Preparation of submicroparticles of β-sitosterol |
Powdered submicroparticles of β-sitosterol exhibited improved solubility. |
[98] |
ASES |
Itraconazole |
Preparation of solid-inclusion complexes of itraconazole with HP-β-CD |
ASES-processed ITR-HP-β-CD inclusion complex solid powder showed 90% drug dissolution within 10 minutes. |
[99] |